Early Prognostic Value of High-Sensitivity Troponin T after Coronary Artery Bypass Grafting

Mauricio Nassau Machado1,2, Fernando Bruetto Rodrigues3, Ingrid Hellen Grigolo4

  • 1Cardiac Surgery Intensive Care Unit, Hospital de Base, São José do Rio Preto Medical School, São José do Rio Preto, Brazil.

Insights

Elevated high-sensitivity troponin T (hsTnT) levels after coronary artery bypass grafting (CABG) are linked to increased 30-day mortality. Early detection of myocardial injury using hsTnT can help predict patient outcomes post-CABG.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Biomarkers

Background:

  • Periprocedural myocardial injury after coronary artery bypass grafting (CABG) can impact patient prognosis.
  • Factors contributing to myocardial injury post-CABG may extend beyond atherosclerotic plaque instability.
  • Diagnosing myocardial injury after CABG presents challenges.

Purpose of the Study:

  • To investigate the association between early postoperative elevation of high-sensitivity troponin T (hsTnT) and 30-day all-cause mortality following CABG.
  • To identify predictors of mortality in patients undergoing CABG.

Main Methods:

  • A cohort of 600 consecutive patients undergoing CABG was studied.
  • High-sensitivity troponin T (hsTnT) levels were measured pre-surgery and on the first postoperative day.
  • Multivariate Cox proportional hazard analysis was employed to identify independent predictors of mortality.

Main Results:

  • The median hsTnT level on the first postoperative day was 235 ng/L.
  • A higher postoperative hsTnT ratio to the upper reference limit was a significant predictor of mortality (HR=1.06).
  • Age was also identified as an independent predictor of 30-day mortality (HR=1.13).

Conclusions:

  • Elevated postoperative hsTnT levels are reliable predictors of all-cause 30-day mortality after CABG.
  • Patient age is another independent predictor of 30-day mortality post-CABG.
  • These findings highlight the importance of monitoring hsTnT for risk stratification in CABG patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
455
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
270
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
374
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
689
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.3K